+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Drug Screening Market by Product (Consumables, Instruments, Services), Sample Type (Breath Samples, Hair Samples, Oral Fluid Samples), End User - Forecast 2024-2030

  • PDF Icon

    Report

  • 189 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5674413
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Drug Screening Market size was estimated at USD 8.66 billion in 2023, USD 9.89 billion in 2024, and is expected to grow at a CAGR of 14.42% to reach USD 22.25 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Drug Screening Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Drug Screening Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Drug Screening Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AccuSourceHR, Inc., ACM Global Laboratories, Alfa Scientific Designs, Inc., Bio-Rad Laboratories, Inc., Clinical Reference Laboratory, Inc., Cordant Health Solutions, Danaher Corporation, Drägerwerk AG & Co. KGaA, F. Hoffmann-La Roche Ltd., Intoximeters, Inc., Laboratory Corporation of America Holdings, Lifeloc Technologies, Inc., Mayo Clinic Laboratories, Omega Laboratories, Inc. by Juno Pharmaceuticals Corp., OraSure Technologies, Inc., Premier Biotech, LLC, Psychemedics Corporation, Quest Diagnostics Incorporated, Securetec Detektions-Systeme AG, Shimadzu Corporation, Siemens AG, Synens SAS, Thermo Fisher Scientific Inc., and United States Drug Testing Laboratories, Inc.

Market Segmentation & Coverage

This research report categorizes the Drug Screening Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Consumables
      • Assay Kits
      • Calibrators & Controls
      • Sample Collection Tubes
    • Instruments
      • Analytical Instruments
        • Breathalyzers
          • Fuel-Cell Breathalyzers
          • Semiconductor Breathalyzers
        • Chromatography Instruments
        • Immunoassay Analyzers
      • Rapid Testing Devices
        • Oral Fluid Testing Devices
        • Urine Testing Devices
          • Dip Cards
          • Drug Testing Cassettes
          • Drug Testing Cups
    • Services
  • Sample Type
    • Breath Samples
    • Hair Samples
    • Oral Fluid Samples
    • Urine Samples
  • End User
    • Criminal Justice Systems & Law Enforcement Agencies
    • Drug Testing Laboratories
    • Drug Treatment Centers
    • Hospitals
    • Individual Users
    • Pain Management Centers
    • Schools & Colleges
    • Workplaces
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Drug Screening Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Drug Screening Market?
  3. What are the technology trends and regulatory frameworks in the Drug Screening Market?
  4. What is the market share of the leading vendors in the Drug Screening Market?
  5. Which modes and strategic moves are suitable for entering the Drug Screening Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drug Screening Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing consumption drugs and alcoholic substances among population
5.1.1.2. Enforcement of regulations mandating substance abuse screening for safety purposes
5.1.1.3. Need for monitoring and combating substance abuse
5.1.2. Restraints
5.1.2.1. Possibility of manipulation of drug screening results
5.1.3. Opportunities
5.1.3.1. Development of innovative drug screening technologies and kits
5.1.3.2. Technological advancements to improve the accuracy of drug screening
5.1.4. Challenges
5.1.4.1. Lack of standard regulatory framework for drug screening across economies
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Drug Screening Market, by Product
6.1. Introduction
6.2. Consumables
6.3.1. Assay Kits
6.3.2. Calibrators & Controls
6.3.3. Sample Collection Tubes
6.3. Instruments
6.4.1. Analytical Instruments
6.4.2.1. Breathalyzers
6.4.2.2.1. Fuel-Cell Breathalyzers
6.4.2.2.2. Semiconductor Breathalyzers
6.4.2.2. Chromatography Instruments
6.4.2.3. Immunoassay Analyzers
6.4.2. Rapid Testing Devices
6.4.3.1. Oral Fluid Testing Devices
6.4.3.2. Urine Testing Devices
6.4.3.3.1. Dip Cards
6.4.3.3.2. Drug Testing Cassettes
6.4.3.3.3. Drug Testing Cups
6.4. Services
7. Drug Screening Market, by Sample Type
7.1. Introduction
7.2. Breath Samples
7.3. Hair Samples
7.4. Oral Fluid Samples
7.5. Urine Samples
8. Drug Screening Market, by End User
8.1. Introduction
8.2. Criminal Justice Systems & Law Enforcement Agencies
8.3. Drug Testing Laboratories
8.4. Drug Treatment Centers
8.5. Hospitals
8.6. Individual Users
8.7. Pain Management Centers
8.8. Schools & Colleges
8.9. Workplaces
9. Americas Drug Screening Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Drug Screening Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Drug Screening Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Abbott Laboratories
13.1.2. AccuSourceHR, Inc.
13.1.3. ACM Global Laboratories
13.1.4. Alfa Scientific Designs, Inc.
13.1.5. Bio-Rad Laboratories, Inc.
13.1.6. Clinical Reference Laboratory, Inc.
13.1.7. Cordant Health Solutions
13.1.8. Danaher Corporation
13.1.9. Drägerwerk AG & Co. KGaA
13.1.10. F. Hoffmann-La Roche Ltd.
13.1.11. Intoximeters, Inc.
13.1.12. Laboratory Corporation of America Holdings
13.1.13. Lifeloc Technologies, Inc.
13.1.14. Mayo Clinic Laboratories
13.1.15. Omega Laboratories, Inc. by Juno Pharmaceuticals Corp.
13.1.16. OraSure Technologies, Inc.
13.1.17. Premier Biotech, LLC
13.1.18. Psychemedics Corporation
13.1.19. Quest Diagnostics Incorporated
13.1.20. Securetec Detektions-Systeme AG
13.1.21. Shimadzu Corporation
13.1.22. Siemens AG
13.1.23. Synens SAS
13.1.24. Thermo Fisher Scientific Inc.
13.1.25. United States Drug Testing Laboratories, Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. DRUG SCREENING MARKET RESEARCH PROCESS
FIGURE 2. DRUG SCREENING MARKET SIZE, 2023 VS 2030
FIGURE 3. DRUG SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. DRUG SCREENING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. DRUG SCREENING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. DRUG SCREENING MARKET DYNAMICS
FIGURE 7. DRUG SCREENING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. DRUG SCREENING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
FIGURE 10. DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. DRUG SCREENING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 12. DRUG SCREENING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES DRUG SCREENING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES DRUG SCREENING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. DRUG SCREENING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. DRUG SCREENING MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. DRUG SCREENING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. DRUG SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DRUG SCREENING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. DRUG SCREENING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 8. DRUG SCREENING MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. DRUG SCREENING MARKET SIZE, BY CALIBRATORS & CONTROLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. DRUG SCREENING MARKET SIZE, BY SAMPLE COLLECTION TUBES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 13. DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 15. DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 17. DRUG SCREENING MARKET SIZE, BY FUEL-CELL BREATHALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. DRUG SCREENING MARKET SIZE, BY SEMICONDUCTOR BREATHALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. DRUG SCREENING MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 23. DRUG SCREENING MARKET SIZE, BY ORAL FLUID TESTING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 26. DRUG SCREENING MARKET SIZE, BY DIP CARDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. DRUG SCREENING MARKET SIZE, BY DRUG TESTING CASSETTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. DRUG SCREENING MARKET SIZE, BY DRUG TESTING CUPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. DRUG SCREENING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 31. DRUG SCREENING MARKET SIZE, BY BREATH SAMPLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. DRUG SCREENING MARKET SIZE, BY HAIR SAMPLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. DRUG SCREENING MARKET SIZE, BY ORAL FLUID SAMPLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. DRUG SCREENING MARKET SIZE, BY URINE SAMPLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. DRUG SCREENING MARKET SIZE, BY CRIMINAL JUSTICE SYSTEMS & LAW ENFORCEMENT AGENCIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. DRUG SCREENING MARKET SIZE, BY DRUG TESTING LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. DRUG SCREENING MARKET SIZE, BY DRUG TREATMENT CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. DRUG SCREENING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. DRUG SCREENING MARKET SIZE, BY INDIVIDUAL USERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. DRUG SCREENING MARKET SIZE, BY PAIN MANAGEMENT CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. DRUG SCREENING MARKET SIZE, BY SCHOOLS & COLLEGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. DRUG SCREENING MARKET SIZE, BY WORKPLACES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. CANADA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 73. CANADA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 74. CANADA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 75. CANADA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 76. CANADA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 77. CANADA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 78. CANADA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 79. CANADA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 80. CANADA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. MEXICO DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. MEXICO DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 83. MEXICO DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 84. MEXICO DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 85. MEXICO DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 86. MEXICO DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 87. MEXICO DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 88. MEXICO DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 89. MEXICO DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES DRUG SCREENING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 100. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 101. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 102. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 103. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 104. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 106. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 108. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 110. AUSTRALIA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 111. AUSTRALIA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 112. AUSTRALIA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 113. AUSTRALIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 114. AUSTRALIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 115. AUSTRALIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 116. AUSTRALIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 117. AUSTRALIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 118. AUSTRALIA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. CHINA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 120. CHINA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 121. CHINA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 122. CHINA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 123. CHINA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 124. CHINA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 125. CHINA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 126. CHINA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 127. CHINA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. INDIA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 129. INDIA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 130. INDIA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 131. INDIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 132. INDIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 133. INDIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 134. INDIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 135. INDIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 136. INDIA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. INDONESIA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 138. INDONESIA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 139. INDONESIA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 140. INDONESIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 141. INDONESIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 142. INDONESIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 143. INDONESIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 144. INDONESIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 145. INDONESIA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 146. JAPAN DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 147. JAPAN DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 148. JAPAN DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 149. JAPAN DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 150. JAPAN DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 151. JAPAN DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 152. JAPAN DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 153. JAPAN DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 154. JAPAN DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 155. MALAYSIA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 156. MALAYSIA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 157. MALAYSIA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 158. MALAYSIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 159. MALAYSIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 160. MALAYSIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 161. MALAYSIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 162. MALAYSIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 163. MALAYSIA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 164. PHILIPPINES DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 165. PHILIPPINES DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 166. PHILIPPINES DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 167. PHILIPPINES DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 168. PHILIPPINES DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 169. PHILIPPINES DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 170. PHILIPPINES DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 171. PHILIPPINES DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 172. PHILIPPINES DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. SINGAPORE DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 174. SINGAPORE DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 175. SINGAPORE DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 176. SINGAPORE DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 177. SINGAPORE DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 178. SINGAPORE DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 179. SINGAPORE DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 180. SINGAPORE DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 181. SINGAPORE DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. SOUTH KOREA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 183. SOUTH KOREA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 184. SOUTH KOREA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 185. SOUTH KOREA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 186. SOUTH KOREA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 187. SOUTH KOREA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 188. SOUTH KOREA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 189. SOUTH KOREA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 190. SOUTH KOREA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 191. TAIWAN DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 192. TAIWAN DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 193. TAIWAN DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 194. TAIWAN DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 195. TAIWAN DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 196. TAIWAN DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 197. TAIWAN DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 198. TAIWAN DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 199. TAIWAN DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. THAILAND DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 201. THAILAND DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 202. THAILAND DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 203. THAILAND DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 204. THAILAND DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 205. THAILAND DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 206. THAILAND DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 207. THAILAND DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 208. THAILAND DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. VIETNAM DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 210. VIETNAM DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 211. VIETNAM DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 212. VIETNAM DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 213. VIETNAM DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 214. VIETNAM DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 215. VIETNAM DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 216. VIETNAM DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 217. VIETNAM DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 228. DENMARK DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 229. DENMARK DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 230. DENMARK DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 231. DENMARK DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 232. DENMARK DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 233. DENMARK DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 234. DENMARK DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 235. DENMARK DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 236. DENMARK DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. EGYPT DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 238. EGYPT DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 239. EGYPT DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 240. EGYPT DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 241. EGYPT DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 242. EGYPT DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 243. EGYPT DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 244. EGYPT DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 245. EGYPT DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. FINLAND DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 247. FINLAND DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 248. FINLAND DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 249. FINLAND DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 250. FINLAND DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 251. FINLAND DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 252. FINLAND DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 253. FINLAND DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 254. FINLAND DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 255. FRANCE DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 256. FRANCE DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 257. FRANCE DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 258. FRANCE DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 259. FRANCE DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 260. FRANCE DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 261. FRANCE DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 262. FRANCE DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 263. FRANCE DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. GERMANY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 265. GERMANY DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 266. GERMANY DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 267. GERMANY DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 268. GERMANY DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 269. GERMANY DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 270. GERMANY DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 271. GERMANY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 272. GERMANY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 273. ISRAEL DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 274. ISRAEL DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 275. ISRAEL DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 276. ISRAEL DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 277. ISRAEL DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 278. ISRAEL DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 279. ISRAEL DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 280. ISRAEL DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 281. ISRAEL DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 282. ITALY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 283. ITALY DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 284. ITALY DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 285. ITALY DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 286. ITALY DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 287. ITALY DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 288. ITALY DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 289. ITALY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 290. ITALY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 291. NETHERLANDS DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 292. NETHERLANDS DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 293. NETHERLANDS DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 294. NETHERLANDS DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 295. NETHERLANDS DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 296. NETHERLANDS DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 297. NETHERLANDS DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 298. NETHERLANDS DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 299. NETHERLANDS DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 300. NIGERIA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 301. NIGERIA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 302. NIGERIA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 303. NIGERIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 304. NIGERIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 305. NIGERIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 306. NIGERIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 307. NIGERIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 308. NIGERIA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 309. NORWAY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 310. NORWAY DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 311. NORWAY DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 312. NORWAY DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 313. NORWAY DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 314. NORWAY DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 315. NORWAY DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 316. NORWAY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 317. NORWAY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 318. POLAND DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 319. POLAND DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 320. POLAND DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 321. POLAND DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 322. POLAND DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 323. POLAND DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 324. POLAND DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 325. POLAND DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 326. POLAND DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 327. QATAR DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 328. QATAR DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 329. QATAR DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 330. QATAR DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 331. QATAR DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 332. QATAR DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 333. QATAR DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 334. QATAR DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 335. QATAR DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 336. RUSSIA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 337. RUSSIA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 338. RUSSIA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 339. RUSSIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 340. RUSSIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 341. RUSSIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 342. RUSSIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 343. RUSSIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 344. RUSSIA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 345. SAUDI ARABIA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 346. SAUDI ARABIA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 347. SAUDI ARABIA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 348. SAUDI ARABIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 349. SAUDI ARABIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 350. SAUDI ARABIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 351. SAUDI ARABIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 352. SAUDI ARABIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 353. SAUDI ARABIA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 354. SOUTH AFRICA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 355. SOUTH AFRICA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 356. SOUTH AFRICA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 357. SOUTH AFRICA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 358. SOUTH AFRICA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 359. SOUTH AFRICA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 360. SOUTH AFRICA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 361. SOUTH AFRICA DRUG SCREENING MARKET SIZE,

Companies Mentioned

  • Abbott Laboratories
  • AccuSourceHR, Inc.
  • ACM Global Laboratories
  • Alfa Scientific Designs, Inc.
  • Bio-Rad Laboratories, Inc.
  • Clinical Reference Laboratory, Inc.
  • Cordant Health Solutions
  • Danaher Corporation
  • Drägerwerk AG & Co. KGaA
  • F. Hoffmann-La Roche Ltd.
  • Intoximeters, Inc.
  • Laboratory Corporation of America Holdings
  • Lifeloc Technologies, Inc.
  • Mayo Clinic Laboratories
  • Omega Laboratories, Inc. by Juno Pharmaceuticals Corp.
  • OraSure Technologies, Inc.
  • Premier Biotech, LLC
  • Psychemedics Corporation
  • Quest Diagnostics Incorporated
  • Securetec Detektions-Systeme AG
  • Shimadzu Corporation
  • Siemens AG
  • Synens SAS
  • Thermo Fisher Scientific Inc.
  • United States Drug Testing Laboratories, Inc.

Methodology

Loading
LOADING...

Table Information